Bile acids for liver-transplanted patients

Goran Poropat; Vanja Giljaca; Davor Stimac; Christian Gluud

doi:10.1002/14651858.CD005442.pub2

Bile acids for liver-transplanted patients

Goran Poropat
, Vanja Giljaca
, Davor Stimac
, Christian Gluud

Copenhagen Trial Unit Rigshospitalet

11 Citationer (Scopus)

Abstract

Liver transplantation has become a widely accepted form of treatment for numerous end-stage liver diseases. Bile acids may decrease allograft rejection after liver transplantation by changing the expression of major histocompatibility complex class molecules in bile duct epithelium and central vein endothelium.

Originalsprog	Engelsk
Tidsskrift	Cochrane Database of Systematic Reviews
Udgave nummer	3
Sider (fra-til)	CD005442
ISSN	1469-493X
DOI	https://doi.org/10.1002/14651858.CD005442.pub2
Status	Udgivet - 1 jan. 2010

Adgang til dokumentet

10.1002/14651858.CD005442.pub2

Citationsformater

@article{6d2411d91b904957b26aeba5e7af915d,

title = "Bile acids for liver-transplanted patients",

abstract = "Liver transplantation has become a widely accepted form of treatment for numerous end-stage liver diseases. Bile acids may decrease allograft rejection after liver transplantation by changing the expression of major histocompatibility complex class molecules in bile duct epithelium and central vein endothelium.",

author = "Goran Poropat and Vanja Giljaca and Davor Stimac and Christian Gluud",

year = "2010",

month = jan,

day = "1",

doi = "10.1002/14651858.CD005442.pub2",

language = "English",

pages = "CD005442",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "3",

}

TY - JOUR

T1 - Bile acids for liver-transplanted patients

AU - Poropat, Goran

AU - Giljaca, Vanja

AU - Stimac, Davor

AU - Gluud, Christian

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Liver transplantation has become a widely accepted form of treatment for numerous end-stage liver diseases. Bile acids may decrease allograft rejection after liver transplantation by changing the expression of major histocompatibility complex class molecules in bile duct epithelium and central vein endothelium.

AB - Liver transplantation has become a widely accepted form of treatment for numerous end-stage liver diseases. Bile acids may decrease allograft rejection after liver transplantation by changing the expression of major histocompatibility complex class molecules in bile duct epithelium and central vein endothelium.

U2 - 10.1002/14651858.CD005442.pub2

DO - 10.1002/14651858.CD005442.pub2

M3 - Journal article

C2 - 20238339

SN - 1469-493X

SP - CD005442

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 3

ER -

Bile acids for liver-transplanted patients

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater